Efficacy and safety of cyclosporine A in patients with refractory systemic lupus erythematosus in a daily clinical practice.

Ogawa, H; Kameda, H; Amano, K; Takeuchi, T

Ogawa, H; Kameda, H; Amano, K; Takeuchi, T.

Affiliation

Ogawa H; Department of Rheumatology/Clinical Immunology, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama 350-8550, Japan.

Lupus ; 19(2): 162-9, 2010 Feb.

Article in En | MEDLINE | ID: mdl-19952069

Subject(s)

Cyclosporine/therapeutic use; Immunosuppressive Agents/therapeutic use; Lupus Erythematosus, Systemic/drug therapy; Lupus Nephritis/drug therapy; Adolescent; Adult; Aged; Cyclosporine/administration & dosage; Cyclosporine/adverse effects; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glucocorticoids/therapeutic use; Humans; Immunosuppressive Agents/administration & dosage; Immunosuppressive Agents/adverse effects; Lupus Erythematosus, Systemic/mortality; Lupus Erythematosus, Systemic/physiopathology; Lupus Nephritis/physiopathology; Male; Middle Aged; Proteinuria/drug therapy; Proteinuria/etiology; Severity of Illness Index; Survival Rate; Treatment Outcome; Young Adult

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lupus Nephritis / Cyclosporine / Immunosuppressive Agents / Lupus Erythematosus, Systemic Type of study: Etiology_studies / Observational_studies / Prognostic_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Lupus Journal subject: REUMATOLOGIA Year: 2010 Document type: Article Affiliation country: Japan Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google